Avenir Wellness Solutions, Inc. financial data

Symbol
AVRW on OTC
Industry
Pharmaceutical Preparations
Location
5805 Sepulveda Blvd., Suite 801, Sherman Oaks, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Cure Pharmaceutical Holding Corp. (to 11/21/2022), Makkanotti Group Corp. (to 11/15/2016)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 10.7 % -73.5%
Quick Ratio 1.45 % -44.1%
Debt-to-equity -119 % +49.9%
Return On Assets -215 % -38.2%
Operating Margin -276 % -13.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 78M shares +8.77%
Common Stock, Shares, Outstanding 78M shares +8.78%
Entity Public Float 5.7M USD -54%
Common Stock, Value, Issued 78K USD +8.33%
Weighted Average Number of Shares Outstanding, Basic 69.9M shares +16.8%
Weighted Average Number of Shares Outstanding, Diluted 69.9M shares +16.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 287K USD -70.5%
Research and Development Expense 2.02M USD -23.1%
Operating Income (Loss) -715K USD +52.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.54M USD +80%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -4.44M USD +62.8%
Earnings Per Share, Basic -0.29 USD/shares +62.3%
Earnings Per Share, Diluted -0.29 USD/shares +61.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 19K USD -89.1%
Accounts Receivable, after Allowance for Credit Loss, Current 49K USD -71.2%
Inventory, Net 151K USD -46.3%
Other Assets, Current 7K USD -85.1%
Assets, Current 320K USD -88.7%
Property, Plant and Equipment, Net 3K USD 0%
Operating Lease, Right-of-Use Asset 146K USD +36.4%
Intangible Assets, Net (Excluding Goodwill) 218K USD
Goodwill 0 USD -100%
Assets 1.03M USD -72.2%
Accounts Payable, Current 2.28M USD +79.9%
Accrued Liabilities, Current 1.45M USD -1.43%
Liabilities, Current 13M USD +12%
Operating Lease, Liability, Noncurrent 74K USD
Liabilities 13M USD +12.7%
Retained Earnings (Accumulated Deficit) -126M USD -3.67%
Stockholders' Equity Attributable to Parent -12M USD -52.7%
Liabilities and Equity 1.03M USD -72.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -618K USD +56%
Net Cash Provided by (Used in) Financing Activities -16K USD +74.6%
Net Cash Provided by (Used in) Investing Activities 614K USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 78M shares +8.78%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.5M USD -392%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 19K USD -89.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 7K USD +133%
Deferred Tax Assets, Valuation Allowance 10.1M USD -7.51%
Operating Lease, Liability 139K USD +26.4%
Depreciation 1K USD 0%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 199K USD
Operating Lease, Liability, Current 65K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.14 pure +26.5%
Deferred Tax Assets, Operating Loss Carryforwards 10M USD +32.5%
Additional Paid in Capital 113M USD +0.53%
Amortization of Intangible Assets 18K USD 0%
Share-based Payment Arrangement, Expense 5K USD -93.3%
Interest Expense 44K USD 0%